Communications

Re-evaluating your internal and external comms activities to adapt to the continuously shifting situation?

RESOURCES

Assessing and managing issues around clinical trials: a multi-stakeholder approach

Many companies are facing challenging decisions on whether to proceed with clinical trials in the coming months as countries experience varying degrees of lockdown.

View

Maintaining noise about other healthcare conditions

How we remember the COVID-19 pandemic will be decided by the journalists of today who are editing and documenting these unusual times.

View

Best practices for communicating clinical trial changes and delays

In the case of COVID-19, clinical trials – like many other planned activities – have been impacted and many companies have been forced to make some tough choices. When making the difficult, yet necessary, decision to delay a trial, communicating clearly and strategically across all affected audiences is critically important.

View

Unlocking virtual medical congresses

Medical congresses – crucial for the presentation of trial data, scientific exchange and the opportunity to engage with medical professionals, patient advocates, media and analysts – have been cancelled, postponed or are moving to virtual/part virtual.

View

No two virtual congresses are the same

Each congress has a different structure to its overall program and method in delivering its scientific information, despite stating that they all plan to keep to the traditional congress format

Download PDF

Get in Touch

We know there are numerous considerations when it comes to the impact of COVID-19 on clinical trials and what this means for your organization. We are here to help.